(Q37074825)

18 August 2017

Treatment of ocular myasthenia with corticotrophin (English)

1 reference

18 August 2017

Gibberd FB

1

1 reference

18 August 2017

Navab F

series ordinal

2

1 reference

18 August 2017

Smith CL

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 1971

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

18 August 2017

1 reference

18 August 2017

34

1 reference

18 August 2017

1

1 reference

18 August 2017

11-13

1 reference

EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

MYASTHENIA GRAVIS AND AUTO-IMMUNE DISEASE: REVIEW OF THE LITERATURE INCLUDING A CASE REPORT OF THE COEXISTENCE OF MYASTHENIA AND SYSTEMIC LUPUS ERYTHEMATOSUS.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

CORTICOTROPIN IN TREATMENT OF OCULAR MYASTHENIA; A CONTROLLED CLINICAL TRIAL.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

Studies in myasthenia gravis. Short-term massive corticotropin therapy

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493678

Treatment of severe myasthenia gravis with large doses of ACTH

4 September 2018

1 reference

12 December 2020

The autoimmune response in myasthenia gravis

1 reference

12 December 2020

ACTH FOR OCULAR MYASTHENIA

1 reference

12 December 2020

REACTIVITY OF MYASTHENIA GRAVIS SERUM GAMMA-GLOBULIN WITH SKELETAL MUSCLE AND THYMUS DEMONSTRATED BY IMMUNOFLUORESCENCE

1 reference

12 December 2020

The place of corticotropin in the treatment of myasthenia gravis

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.34.1.11

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

4323972

1 reference